Determinants of Angiographic Thrombus Burden in Patients With ST-Segment Elevation Myocardial Infarction

Author(s): Tanboga IH, Topcu S, Aksakal E, Kalkan K, Sevimli S

Abstract

Aims:

We aimed to investigate the determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (pPCI).

Methods:

The study population consisted of 662 patients with nonanemic STEMI who underwent pPCI. Clinical, laboratory, and demographic properties of the patients were recorded. Baseline hematologic indices were measured at the time of admission. Angiographic coronary thrombus burden was scored based on thrombolysis in myocardial infarction (TIMI) thrombus grades. After wiring and/or small balloon dilation, patients with thrombus burden grades 4 and 5 were defined as high thrombus burden, and patients with thrombus burden <grade 4 was defined as low thrombus burden.

Result:

Patients with high thrombus burden had more family history of coronary artery disease, longer pain to balloon time, higher Killip class (≥II), higher neutrophil to lymphocyte ratio, red cell distribution width (RDW), baseline creatine kinase-MB fraction (CK-MB) and baseline troponin, higher peak CK-MB, and peak troponinbut lower triglycerides. Angiographically, patients with high thrombus burden had longer lesion in the infarct-related artery, less frequent direct stenting, lower epicardial and myocardial perfusion, more frequent distal embolization, and more frequent electrocardiographic and angiographic no reflow. In multivariate logistic regression analysis, only RDW (odds ratio: 1.29, 95% confidence interval 1.19-1.39, P < .001) was determined as independent predictor. The area under the receiver–operating characteristic curve of the RDW was 0.733 (0.690-0.776, P < .001) to predict high TIMI thrombus burden.

Similar Articles

Global Atlas on Cardiovascular Disease Prevention and Control.

Author(s): Mendis S, Puska P, Norrving B

Pathogenesis of Acute Coronary Syndromes

Author(s): Crea F, Liuzzo G

Mechanisms of Plaque Formation and Rupture

Author(s): Bentzon JF, Otsuka F, Virmani R, Falk E

Matrix Metalloproteinase-9?: Many Shades of Function in Cardiovascular Disease.

Author(s): Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML

Association of serum MMP-9 with autoantibodies against oxidized LDL

Author(s): Kalela A, Koivu TA, Höyhtyä M, Jaakkola O, Lehtimäki T

2013 ESC guidelines on the management of stable coronary artery disease: Eur Heart

Author(s): Montalescot G, Sechtem U, Achenbach S, Andreotti F

Chronic Stable Angina.

Author(s): Abrams J

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

Author(s): Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A

The oxidation ratio of LDL: a predictor for coronary artery disease.

Author(s): Huang H, Mai W, Liu D, Hao Y, Tao J

Antibodies against oxLDL and acute coronary syndrome.

Author(s): Medeiros AM, von Mühlen CA, Gidlund MA, Bodanese R, Gottlieb MG

Plaque regression and plaque stabilisation in cardiovascular diseases.

Author(s): Dave T, Ezhilan J, Vasnawala H, Somani V

Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease

Author(s): Kalela A, Koivu TA, Sisto T, Kanervisto J, Höyhtyä M